- Home
- Supplements
- Niacinamide
- Acne & Breakouts
Niacinamide for Acne & Breakouts
Topical niacinamide at 4 to 5 percent reduces inflammatory acne lesions about as well as topical clindamycin, without resistance concerns. Oral niacinamide for acne is far less supported.
Overview
Verdict
Small randomised trials of topical 4-5% niacinamide show inflammatory lesion reductions comparable to topical clindamycin over 8 weeks. Oral evidence is weaker and mostly from combination products.
How It Works
Pathways involved
Dosing & Protocol
| Context | Dose | Form | Timing |
|---|---|---|---|
| Trial dose (topical) | 5% nicotinamide gel, twice daily | Nicotinamide gel | Applied to affected areas after cleansing |
| Common cosmetic dose | 4-5% niacinamide serum, once or twice daily | Niacinamide | Leave-on, before moisturiser |
| Sensitive skin start | 2% niacinamide, once daily | Niacinamide | Build up over 2 weeks |
| Oral (adjunct only) | 500 mg daily | Nicotinamide | With food |
- 1
Patch test and start once daily· Week 1
Apply a pea-sized amount to one area for a few days. Flushing or stinging usually means the formula concentration is too high, not that niacinamide is unsuitable.
- 2
Move to twice daily on clean skin· Weeks 2-8
Morning and night after cleansing, before moisturiser and sunscreen. The trial regimen was twice daily for eight weeks.
- 3
Judge at eight weeks· Week 8
Count inflammatory lesions at baseline and again at eight weeks. That is the window in which the randomised comparison with clindamycin showed its effect.
- 4
Layer a comedolytic if needed· Ongoing
If comedones persist while redness improves, add an adapalene or salicylic acid step at night rather than increasing niacinamide.
Higher percentages are not better
Formulas above 5% raise the rate of stinging and flushing without evidence of extra benefit. The randomised data sit at 4-5%.
Evidence
Studies linked to this pairing.
Comparison of topical 5% nicotinamide gel versus 2% clindamycin gel in mild to moderate acne vulgaris: a double-blinded randomized clinical trial
Khodaeiani E, Fouladi RF, Amirnia M
Topical nicotinamide gel matched clindamycin for acne lesion reduction.
- Best available evidence
- Double-blinded RCT versus topical clindamycin, plus small supporting trials
- Typical effect
- Inflammatory lesion reduction comparable to 2% clindamycin at 8 weeks
- Studied dose
- 5% nicotinamide gel twice daily
- Time to effect
- 4-8 weeks
- Main limitation
- Small samples, short follow-up, few placebo-controlled arms
Safety
Flushing means niacin, not niacinamide
Niacinamide does not cause the prostaglandin-mediated flush associated with nicotinic acid. Persistent stinging on application is usually the vehicle or an over-concentrated formula.
Common effects
Interactions & Conflicts
| Interacts with | Severity | Mechanism | Action |
|---|---|---|---|
| Topical retinoids | low | Additive barrier disruption and irritation | Alternate nights initially, or apply niacinamide in the morning |
| Benzoyl peroxide | low | Oxidising environment can degrade some formulations | Separate application times morning and evening |
| High-dose oral nicotinamide with carbamazepine | moderate | Reduced carbamazepine clearance reported at gram doses | Keep oral use low and discuss with a prescriber |
References
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.